Publications by authors named "Ruth Ladenstein"

99Publications

The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.

Pediatr Blood Cancer 2020 08 30;67(8):e28359. Epub 2020 May 30.

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.28359DOI Listing
August 2020

The impact of local control in the treatment of children with advanced infantile and adult-type fibrosarcoma: Experience of the cooperative weichteilsarkom studiengruppe (CWS).

J Pediatr Surg 2020 Sep 9;55(9):1740-1747. Epub 2019 Nov 9.

Klinikum Stuttgart - Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pediatrics 5 (Oncology, Hematology, Immunology), Stuttgart, Germany; Children's Hospital, Department of Pediatric Hematology and Oncology, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpedsurg.2019.10.051DOI Listing
September 2020

Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.

Clin Orthop Relat Res 2020 02;478(2):290-302

D. Andreou, G. Gosheger, Department of General Orthopedics and Tumor Orthopedics, University Hospital Münster, Westfälische Wilhelms-University, Münster, Germany A. Ranft, U. Dirksen, Pediatrics III, Hematology/Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany B. Timmermann, Clinic for Particle Therapy, West German Proton Therapy Center, University Hospital Essen, Essen, Germany R. Ladenstein, Department of Studies and Statistics on Integrated Research and Projects (S2IRP), Children's Cancer Research Institute, Vienna, Austria W. Hartmann, E. Wardelmann, Gerhard-Domagk-Institute for Pathology, University Hospital Münster, Westfälische Wilhelms-University, Münster, Germany S. Bauer, Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany D. Baumhoer, Bone Tumor Reference Center, Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland H. van den Berg, Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands P. D. S. Dijkstra, Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, the Netherlands H. R. Dürr, Orthopedic Oncology, Department of Orthopedics, Ludwig-Maximilians University Munich, Campus Grosshadern, Munich, Germany H. Gelderblom, Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands J. Hardes, A Streitbürger, Department of Tumor Orthopedics and Sarcoma Surgery, University Hospital Essen, Essen, Germany L. Hjorth, Department of Paediatrics, Skane University Hospital, Clinical Sciences, Lund University, Lund, Sweden J. Kreyer, Department of Orthopedic and Trauma Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany J. Kruseova, Department of Pediatric Hematology and Oncology, 2nd Medical School, Charles University Prague, Prague, Czech Republic A. Leithner, Department of Orthopedic Surgery, Medical University of Graz, Graz, Austria S. Scobioala, Department of Radiation Oncology, University Hospital Münster, Westfälische Wilhelms-University, Münster, Germany P-U. Tunn, Department of Orthopedic Oncology, HELIOS Klinikum Berlin-Buch, Berlin, Germany R. Windhager, Department of Orthopedics, Medical University of Vienna, Vienna, Austria H. Jürgens, Department of Paediatric Hematology and Oncology, University Hospital Münster, Westfälische Wilhelms-University, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CORR.0000000000000962DOI Listing
February 2020

A European paediatric cancer mission: aspiration or reality?

Lancet Oncol 2019 09;20(9):1200-1202

Department of Pediatrics and Adolescent Medicine, Rigshospitalet University Hospital, and Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30487-5DOI Listing
September 2019

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.

J Clin Oncol 2018 Sep 6:JCO2018782516. Epub 2018 Sep 6.

Jeremy Whelan, University College Hospital; Ian Judson, Institute of Cancer Research, London; Bernadette Brennan, Royal Manchester Children's Hospital, Manchester; Bruce Morland, Birmingham Children's Hospital; Keith Wheatley, University of Birmingham, Birmingham; Ian Lewis, Leeds Community Healthcare National Health Service Trust, Leeds; Alan Craft, Newcastle University, Newcastle upon Tyne, United Kingdom; Marie-Cecile Le Deley and Cyril Lervat, Centre Oscar Lambret, Lille; Gwénaël Le Teuff, Nathalie Gaspar, and Odile Oberlin, Institut Gustave Roussy, Villejuif; Jean-Yves Blay, Centre Léon Bérard; Perrine Marec-Berard, Institute of Pediatric Onco-Haematology, Lyon; Marie-Pierre Castex, Centre Hospitalier Universitaire de Toulouse, Toulouse; Jean-Claude Gentet, Centre Hospitalier Universitaire La Timone, Marseille; Marta Jimenez, Unicancer; Valerie Laurence and Jean Michon, Institut Curie, Paris; France; Uta Dirksen, Sebastian Bauer, Andreas Ranft, University Hospital Essen, Essen; Susanne Amler, Institut für Biometrie und Klinische Forschung; Wolfgang Hartmann and Heribert Juergens, Universitätsklinikum, Münster, Münster; Stefan Bielack, Klinikum Stuttgart, Stuttgart; Stefan Burdach, Comprehensive Cancer Center, München; Dagmar Dilloo, University-Clinic Bonn, Bonn; Angelika Eggert, Charité University; Peter Reichardt, HELIOS Klinikum Berlin-Buch, Berlin; Wolf-Achim Hassenpflug, University Medical Center Hamburg-Eppendorf, Hamburg; Thomas Klingebiel, Childrens University Hospital, Frankfurt; Udo Kontny, University Medical Center Aachen, Aachen; Michael Paulussen, Children's and Adolescents' Hospital, Datteln; Germany; Douglas S. Hawkins, Seattle Children's Hospital, Seattle, WA; Hans Gelderblom, Leiden University Medical Center, Leiden; Hendrik van den Berg, University of Amsterdam, Amsterdam, the Netherlands; Lars Hjorth, Skane University Hospital, Lund, Sweden; Jarmila Kruseova, Faculty Hospital Motol Prague, Prague, Czech Republic; Ruth Ladenstein, St Anna Children's Hospital and Children's Cancer Research Institute, Vienna, Austria; Sandrine Marreaud, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.2516
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.2516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209090PMC
September 2018

Alveolar soft-part sarcoma: Primary metastatic disease and metastatic relapse occurring during long-term follow-up: Treatment results of four Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.

Pediatr Blood Cancer 2018 12 19;65(12):e27405. Epub 2018 Aug 19.

Klinikum Stuttgart-Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend-und Frauenmedizin, Pediatrics 5 (Oncology, Hematology, Immunology), Stuttgart, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.27405
Publisher Site
http://dx.doi.org/10.1002/pbc.27405DOI Listing
December 2018

Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS).

Pediatr Blood Cancer 2018 05 5;65(5):e26943. Epub 2018 Jan 5.

Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pediatrics 5 (Oncology, Hematology, and Immunology), Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26943DOI Listing
May 2018

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

J Clin Oncol 2017 Aug 4;35(22):2580-2587. Epub 2017 May 4.

Julie R. Park, Seattle Children's Hospital and University of Washington School of Medicine, Seattle, WA; Rochelle Bagatell and John M. Maris, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Susan L. Cohn, University of Chicago, Chicago, IL; Andrew D. Pearson, Institute of Cancer Research and Royal Marsden National Health Service (NHS) Foundation Trust, Sutton, Surrey; Susan Burchill, Leeds Institute of Cancer and Pathology, St James University Hospital, Leeds; Kieran McHugh and Penelope Brock, Great Ormond Street Hospital for Children, NHS Trust, London, United Kingdom; Judith G. Villablanca, Children's Hospital Los Angeles and University of Southern California Keck School of Medicine, Los Angeles; Katherine K. Matthay, University of California San Francisco School of Medicine, San Francisco, CA; Frank Berthold, Children's Hospital and University of Cologne, Köln, Germany; Ariane Boubaker, Institute of Radiology, Clinique de La Source, Lausanne, Switzerland; Jed G. Nuchtern, Texas Children's Hospital and Baylor College of Medicine, Houston, TX; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA; Nita L. Seibel and O. Wolf Lindwasser, National Cancer Institute, Bethesda, MD; Gudrun Schleiermacher, Institut Curie, Paris; Dominique Valteau-Couanet, Gustave Roussy, Villejuif, France; and Ruth Ladenstein, Children's Cancer Research Institute, St Anna Children's Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.0177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676955PMC
August 2017

Quality of Survivorship in a Rare Disease: Clinicofunctional Outcome and Physical Activity in an Observational Cohort Study of 618 Long-Term Survivors of Ewing Sarcoma.

J Clin Oncol 2017 May 29;35(15):1704-1712. Epub 2017 Mar 29.

Andreas Ranft, Christiane Hoffmann, Ann-Christin Warby, Claudia Rossig, Uta Dirksen, and Herbert Juergens, University Children's Hospital; Corinna Seidel, and Dieter Rosenbaum, University Hospital Muenster; Michael Paulussen, Witten/Herdecke University, Datteln, Germany; Henk van den Berg, Emma Children's Hospital, Amsterdam, the Netherlands; and Ruth Ladenstein, Children's Cancer Research Institute, Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.6226DOI Listing
May 2017

The prognostic value of early radiographic response in children and adolescents with embryonal rhabdomyosarcoma stage IV, metastases confined to the lungs: A report from the Cooperative Weichteilsarkom Studiengruppe (CWS).

Pediatr Blood Cancer 2017 Oct 17;64(10). Epub 2017 Mar 17.

Olgahospital, Pediatrics 5 (Pediatric Oncology, Hematology, Immunology), Zentrum für Kinder-, Jugend- und Frauenmedizin, Klinikum Stuttgart, Stuttgart, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26510DOI Listing
October 2017

Tumor Touch Imprints as Source for Whole Genome Analysis of Neuroblastoma Tumors.

PLoS One 2016 25;11(8):e0161369. Epub 2016 Aug 25.

Department of Tumor Biology, CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0161369PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999140PMC
July 2017

Interoperability Architecture for a Paediatric Oncology European Reference Network.

Stud Health Technol Inform 2016 ;223:39-45

AIT Austrian Institute of Technology GmbH, Austria.

View Article

Download full-text PDF

Source
April 2017

European Survey on Standards of Care in paediatric oncology centres.

Eur J Cancer 2016 07 28;61:11-9. Epub 2016 Apr 28.

Direction of Clinical Research, The Gustave Roussy and Universite Paris-Sud, 114 Rue Edouard Vaillant, Villejuif 94805, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.03.073DOI Listing
July 2016

Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994-2011.

Cancer Epidemiol 2016 06 4;42:72-81. Epub 2016 Apr 4.

The Children Cancer Research Institute, St. Anna Children's Hospital, Kinderspitalgasse 6, 1090 Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2016.03.015DOI Listing
June 2016

Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group.

Pediatr Blood Cancer 2016 07 22;63(7):1198-206. Epub 2016 Mar 22.

Pediatrics 5, Klinikum Stuttgart, Olgahospital, Stuttgart, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25973DOI Listing
July 2016

Management and Outcome of Ewing Sarcoma of the Head and Neck.

Pediatr Blood Cancer 2016 Apr 24;63(4):604-10. Epub 2015 Dec 24.

Department of Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25830DOI Listing
April 2016

G-CSF Is a Cancer Stem Cell-Specific Growth Factor-Letter.

Cancer Res 2015 Sep 3;75(18):3991. Epub 2015 Sep 3.

Department Studies and Statistics, Children's Cancer Research Institute, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-1445DOI Listing
September 2015

Ewing Sarcoma: Current Management and Future Approaches Through Collaboration.

J Clin Oncol 2015 Sep 24;33(27):3036-46. Epub 2015 Aug 24.

Nathalie Gaspar, Marie-Cecile Le Deley, and Odile Oberlin, Institut Gustave Roussy, Villejuif; Nathalie Gaspar, Marie-Cecile Le Deley, Line Claude, Olivier Delattre, Jean Michon, Perrine Marec-Bérard, and Odile Oberlin, Société Française de Lutte Contre les Cancers et les Leucémies de l'Enfant et de l'Adolescent; Marie-Cecile Le Deley, Paris-Sud University, Le Kremlin-Bicêtre; Line Claude and Perrine Marec-Bérard, Centre Léon-Bérard, Lyon; Olivier Delattre and Jean Michon, Institut Curie, Paris, France; Douglas S. Hawkins, Seattle Children's Hospital, Seattle, WA; Douglas S. Hawkins, Mark L. Bernstein, and Richard B. Womer, Children's Oncology Group; Uta Dirksen and Heribert Juergens, University Hospital Münster, Münster; Uta Dirksen, Michael Paulussen, and Heribert Juergens, Gesellschaft für Pädiatrische Onkologie und Hämatologie; Michael Paulussen, Children's and Adolescents' Hospital, Witten/Herdecke University, Datteln, Germany; Ian J. Lewis, Alder Hey Children's National Health Service (NHS) Foundation Trust, Liverpool; Ian J. Lewis, Robert Grimer, Bernadette Brennan, and Alan W. Craft, Children's Cancer and Leukaemia Group; Robert Grimer, Royal Orthopaedic Hospital, Birmingham; Jeremy Whelan, University College London Hospital NHS Foundation Trust; Ian Judson, Royal Marsden Hospital, London; Bernadette Brennan, Royal Manchester Children's Hospital, Manchester; Alan W. Craft, Royal Victoria Infirmary, Newcastle, United Kingdom; Stefano Ferrari and Piero Picci, Rizzoli Institute, Bologna; Stefano Ferrari, Piero Picci, Roberto Luksch, Italian Sarcoma Group; Roberto Luksch, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy; Heinrich Kovar and Ruth Ladenstein, Children's Cancer Institute, St Anna Kinderkrebsforschung, Wien; Heinrich Kovar and Ruth Ladenstein, Arbeitsgemeinschaft Ambulant Tätiger Pädiatrischer Onkologen und Hämatologen, Vienna, Austria; Jeremy Whelan and Ian Judson, European O

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/27/3036.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.5256
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.5256DOI Listing
September 2015

Bone marrows from neuroblastoma patients: an excellent source for tumor genome analyses.

Mol Oncol 2015 Mar 28;9(3):545-54. Epub 2014 Oct 28.

Tumor Biology, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria; Department of Pediatrics, Medical University of Vienna, Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.10.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528711PMC
March 2015

Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.

J Clin Oncol 2014 Aug 30;32(23):2440-8. Epub 2014 Jun 30.

Odile Oberlin, Gustave Roussy Institute, Villejuif; Marie-Cécile Le Deley, Université Paris-Sud, Le Kremlin-Bicêtre; Jean Michon, Institut Curie, Paris; Perrine Marec-Bérard, Centre Léon-Bérard, Lyon, France; Michael Paulussen, Vestische Kinder-und Jugendklinik Datteln, Witten/Herdecke University, Datteln; Andreas Ranft, Heribert Juergens, and Uta Dirksen, University Hospital Münster, Münster, Germany; Ian Lewis, Alder Hey Children's National Health Service Foundation Trust, Liverpool; Bernadette Brennan, Royal Manchester Children's Hospital, Manchester; Jeremy Whelan, University College London Hospital National Health Service Foundation Trust; Ian Judson, The Royal Marsden Hospital, London; Keith Wheatley, University of Birmingham, Birmingham; Alan Craft, Royal Victoria Infirmary, Newcastle, United Kingdom; Ruth Ladenstein, St Anna Children's Cancer Research Institute, Vienna, Austria; Henk van den Berg, Emma Children Hospital AMC, Amsterdam, the Netherlands; and Lars Hjorth, Skåne University Hospital, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.4833DOI Listing
August 2014

Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study.

J Clin Oncol 2014 Apr 3;32(10):1074-83. Epub 2014 Mar 3.

Virginie F. Viprey and Susan A. Burchill, Leeds Institute of Cancer and Pathology; Walter M. Gregory, Clinical Trials Research Unit, University of Leeds, Leeds; Penelope Brock, Great Ormond Street Hospital, London; Andrew D. Pearson, Institute of Cancer Research/Royal Marsden National Health Service Foundation Trust, Sutton, United Kingdom; Maria V. Corrias and Sandro Dallorso, Gaslini Institute, Genoa; Roberto Luksch, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy; Andrei Tchirkov, Centre Hospitalier Universitaire Clermont-Ferrand and Clermont Université, Université d'Auvergne, Clermont-Ferrand; Dominique Valteau-Couanet, Institut Gustave Roussy, Villejuif, France; Katrien Swerts and Genevieve Laureys, University Hospital Ghent, Ghent, Belgium; Ales Vicha, Charles University and University Hospital Motol, Prague, Czech Republic; Vassilios Papadakis, Agia Sofia Children's Hospital, Athens, Greece; and Ruth Ladenstein, Children's Cancer Research Institute/St Anna Children's Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.3604DOI Listing
April 2014

Towards reducing inequalities: European Standards of Care for Children with Cancer.

Eur J Cancer 2014 Feb 30;50(3):481-5. Epub 2013 Nov 30.

Institute of Child Health, University College London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.11.004DOI Listing
February 2014

Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 study.

MAbs 2013 Sep-Oct;5(5):801-9. Epub 2013 May 31.

Children's Cancer Research Institute and St. Anna Children's Hospital and Department of Paediatric and Adolescent Medicine; Medical University; Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/mabs.25215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851232PMC
May 2014

Results of a quality assurance review of external beam radiation therapy in the International Society of Paediatric Oncology (Europe) Neuroblastoma Group's High-risk Neuroblastoma Trial: a SIOPEN study.

Int J Radiat Oncol Biol Phys 2013 Jan 30;85(1):170-4. Epub 2012 Jun 30.

Department of Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2012.05.004DOI Listing
January 2013

Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.

J Clin Oncol 2010 Jul 14;28(20):3284-91. Epub 2010 Jun 14.

St Anna Children's Hospital, SIRP-CCRI Studies and Statistics on Integrated Research and Projects, Children's Cancer Research Institute, Vienna, Austria.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.22.9864
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.22.9864DOI Listing
July 2010

A Web-based platform for interdisciplinary biomedical research.

Front Biosci (Landmark Ed) 2009 Jan 1;14:2738-46. Epub 2009 Jan 1.

eHealth-systems, Biomedical Engineering, Austrian Research Centers GmbH-ARC, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/3410DOI Listing
January 2009

Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: quality assurance on behalf of SIOPEN-R-NET.

Eur J Cancer 2007 Jan 4;43(2):341-50. Epub 2006 Oct 4.

Children's Cancer Research Laboratory, Cancer Research UK Clinical Centre, St James's University Hospital, Beckett Street, Leeds LS9 7TF, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2006.08.007DOI Listing
January 2007

Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.

Pediatr Blood Cancer 2007 May;48(5):504-9

Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.20888DOI Listing
May 2007

Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.

Mol Immunol 2005 Jul 7;42(11):1311-9. Epub 2005 Apr 7.

Charité Children's Hospital, University Medicine, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2004.12.018DOI Listing
July 2005

Disseminated tumor cells in the bone marrow - chances and consequences of microscopical detection methods.

Cancer Lett 2003 Jul;197(1-2):29-34

Children's Cancer Research Institute, St. Anna Children's Hospital, Kinderspitalgasse 6, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0304-3835(03)00078-8DOI Listing
July 2003

[Cell proliferation and cell death in disseminated tumor cells].

Acta Med Austriaca Suppl 2002 ;59:62-4

Institut für Pathologie, Universität Pécs, Szigeti u. 12, H-7643 Pécs, Ungarn.

View Article

Download full-text PDF

Source
February 2003

[Detection, quantification and characterization of disseminated tumor cells].

Acta Med Austriaca Suppl 2002 ;59:58-61

Children's Cancer Research Institute (CCRI), St. Anna Kinderspital, Kinderspitalgasse 6, A-1090 Wien.

View Article

Download full-text PDF

Source
February 2003

High-dose chemotherapy for solid tumors: results of the EBMT.

Crit Rev Oncol Hematol 2002 Feb;41(2):129-40

EBMT Solid Tumors Working Party, (Chairman Dr G. Rosti), Ospedale Civile, Viale Randi 5, 48100, Ravenna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1040-8428(01)00150-0DOI Listing
February 2002